Jose Mendez, DO
Dermatology · Miramar, FLNPI 1033101175
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,053 of the $1,278 with a category attached, or 82.4%. 17 manufacturers reported payments, led by Johnson & Johnson at 28.8% of the total. Reporting peaked in 2024 at $672 and has fallen 91.2% since, to $59 in 2025. That places this record below the midpoint for dermatology clinicians in FL, where the typical reported total is $2,563.
Across 45 payments — averaging $28.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$368
- AbbVie$194
- E.r. Squibb & Sons, L.L.C.$131
- Amgen$84
- Strata Skin Sciences, Inc.$66
- Incyte Corporation$65
- plus $369 from 11 others
Across 48 payments — averaging $31,890 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$1.2M
- Dermira, Inc.$182K
- LEO Pharma AS$171K
What the payments were for
- Food & beverage$1,05382%
- Education$22518%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 11 | $368 |
| AbbVie | 4 | $194 |
| E.r. Squibb & Sons, L.L.C. | 3 | $131 |
| Amgen | 3 | $84 |
| Strata Skin Sciences, Inc. | 5 | $66 |
| Incyte Corporation | 3 | $65 |
| Kerecis Limited | 2 | $62 |
| Pfizer | 3 | $52 |
| Lilly USA, LLC | 2 | $46 |
| Sun Pharmaceutical Industries Inc. | 1 | $42 |
| Organogenesis Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $31 |
| Boehringer Ingelheim | 1 | $28 |
| Sanofi | 1 | $20 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,278 in reported general payments places this provider in the 35th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 13 | $88,550 |
| Ammonium Lactate | 421 | $10,181 |
| Tacrolimus | 55 | $8,736 |
| Ketoconazole | 521 | $8,404 |
| Mupirocin | 1,476 | $7,953 |
| Acitretin | 12 | $6,603 |
| Clobetasol Propionate | 167 | $6,481 |
| Calcipotriene | 18 | $6,359 |
| Metronidazole | 123 | $4,523 |
| Acyclovir | 17 | $3,660 |
| Hydrocortisone | 319 | $3,261 |
| Pimecrolimus | 16 | $2,579 |
| Clindamycin Phosphate | 80 | $2,399 |
| Ciclopirox | 103 | $2,399 |
| CiclopiroxCiclopirox Olamine | 67 | $1,970 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Miramar
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.